Skip to content
Clinical Trials – home
FinlandBack to Finland

Clinical trials in Vaasa

27 clinical trials in Vaasa, Finland. Every trial is listed in the EU Clinical Trials Register and updated daily.

FinlandOur site in FinlandKliinisetTutkimukset.fi(opens in a new tab)
Vaasa at a glance
27
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

27 trials in Vaasa

Open in trial search
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:F. Hoffmann-La Roche AG
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Pfizer Inc.
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Pfizer Inc.
Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:GSK5764227
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Iohexol
  • Sponsor:University Of Helsinki
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Stemline Therapeutics Inc.
Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:HUS-yhtymae
Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Merck Sharp & Dohme LLC
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Mrna-4157
  • Sponsor:Merck Sharp & Dohme LLC
Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Karolinska University Hospital

Other cities in Finland

The busiest research cities in the country

All 28 cities in Finland

Clinical research in Vaasa

What the registry says about research in the country

01 Oncology - Breast Cancer

Innovative clinical trials focusing on hormone receptor-positive breast cancer treatments, including studies of new therapeutic combinations and advanced treatment strategies.

  • Advanced/Metastatic Breast Cancer Therapies
  • HER2-Positive Treatment Studies
  • Hormone Therapy Innovations

Multiple trials evaluating novel drug combinations and comparing treatment efficacy for various stages of breast cancer.

02 Lung Cancer Research

Comprehensive studies examining new approaches to treating non-small cell lung cancer (NSCLC) and small cell lung cancer, with emphasis on immunotherapy combinations.

  • Immunotherapy Development
  • Advanced NSCLC Treatments
  • Combination Therapy Studies

Research focusing on improving survival rates through innovative treatment combinations and targeted therapies.

03 Prostate Cancer Studies

Research initiatives investigating treatments for advanced prostate cancer, including hormone therapy combinations and innovative therapeutic approaches.

  • Metastatic Disease Management
  • Novel Drug Combinations
  • Treatment Resistance Studies

Trials evaluating new therapeutic strategies for both early-stage and metastatic prostate cancer.

04 Neurological Conditions

Clinical research examining treatments for acute ischemic stroke and related conditions, with focus on preventive therapies and risk reduction.

  • Stroke Prevention
  • Risk Management
  • Novel Therapeutic Approaches

Studies aimed at reducing stroke recurrence and improving patient outcomes through innovative medications.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).